{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:01:32Z","timestamp":1791378092672,"version":"4.3.2"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2010,9,23]],"date-time":"2010-09-23T00:00:00Z","timestamp":1285200000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s00134-010-2045-8","type":"journal-article","created":{"date-parts":[[2010,9,22]],"date-time":"2010-09-22T08:01:18Z","timestamp":1285142478000},"page":"2019-2029","source":"Crossref","is-referenced-by-count":210,"title":["Vascular hyporesponsiveness to vasopressors in septic shock: from bench to bedside"],"prefix":"10.1007","volume":"36","author":[{"given":"B.","family":"Levy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Collin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Sennoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Ducrocq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kimmoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Asfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Meziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,9,23]]},"reference":[{"key":"2045_CR1","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","volume":"29","author":"DC Angus","year":"2001","unstructured":"Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303\u20131310","journal-title":"Crit Care Med"},{"key":"2045_CR2","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/CIRCULATIONAHA.106.678359","volume":"116","author":"MW Merx","year":"2007","unstructured":"Merx MW, Weber C (2007) Sepsis and the heart. Circulation 116:793\u2013802","journal-title":"Circulation"},{"key":"2045_CR3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1540\/jsmr.43.117","volume":"43","author":"N Matsuda","year":"2007","unstructured":"Matsuda N, Hattori Y (2007) Vascular biology in sepsis: pathophysiological and therapeutic significance of vascular dysfunction. J Smooth Muscle Res 43:117\u2013137","journal-title":"J Smooth Muscle Res"},{"key":"2045_CR4","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1164\/ajrccm\/148.6_Pt_1.1638","volume":"148","author":"JG Umans","year":"1993","unstructured":"Umans JG, Wylam ME, Samsel RW, Edwards J, Schumacker PT (1993) Effects of endotoxin in vivo on endothelial and smooth-muscle function in rabbit and rat aorta. Am Rev Respir Dis 148:1638\u20131645","journal-title":"Am Rev Respir Dis"},{"key":"2045_CR5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0140-6736(04)17667-8","volume":"365","author":"D Annane","year":"2005","unstructured":"Annane D, Bellissant E, Cavaillon JM (2005) Septic shock. Lancet 365:63\u201378","journal-title":"Lancet"},{"key":"2045_CR6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF01728326","volume":"22","author":"G Bernardin","year":"1996","unstructured":"Bernardin G, Pradier C, Tiger F, Deloffre P, Mattei M (1996) Blood pressure and arterial lactate level are early indicators of short-term survival in human septic shock. Intensive Care Med 22:17\u201325","journal-title":"Intensive Care Med"},{"key":"2045_CR7","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/00003246-200004000-00006","volume":"28","author":"O Abid","year":"2000","unstructured":"Abid O, Akca S, Haji-Michael P, Vincent JL (2000) Strong vasopressor support may be futile in the intensive care unit patient with multiple organ failure. Crit Care Med 28:947\u2013949","journal-title":"Crit Care Med"},{"key":"2045_CR8","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1186\/cc3891","volume":"9","author":"B Lamia","year":"2005","unstructured":"Lamia B, Chemla D, Richard C, Teboul JL (2005) Clinical review: interpretation of arterial pressure wave in shock states. Crit Care 9:601\u2013606","journal-title":"Crit Care"},{"key":"2045_CR9","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1097\/TA.0b013e31811f3a45","volume":"64","author":"S Benchekroune","year":"2008","unstructured":"Benchekroune S, Karpati PC, Berton C, Nathan C, Mateo J, Chaara M, Riche F, Laisne MJ, Payen D, Mebazaa A (2008) Diastolic arterial blood pressure: a reliable early predictor of survival in human septic shock. J Trauma 64:1188\u20131195","journal-title":"J Trauma"},{"key":"2045_CR10","first-page":"165","volume":"38","author":"CR Benedict","year":"1992","unstructured":"Benedict CR, Rose JA (1992) Arterial norepinephrine changes in patients with septic shock. Circ Shock 38:165\u2013172","journal-title":"Circ Shock"},{"key":"2045_CR11","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMra002709","volume":"345","author":"DW Landry","year":"2001","unstructured":"Landry DW, Oliver JA (2001) The pathogenesis of vasodilatory shock. N Engl J Med 345:588\u2013595","journal-title":"N Engl J Med"},{"key":"2045_CR12","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.freeradbiomed.2004.06.034","volume":"37","author":"S Alvarez","year":"2004","unstructured":"Alvarez S, Boveris A (2004) Mitochondrial nitric oxide metabolism in rat muscle during endotoxemia. Free Radic Biol Med 37:1472\u20131478","journal-title":"Free Radic Biol Med"},{"key":"2045_CR13","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1161\/01.ATV.0000161048.72004.c2","volume":"25","author":"JO Lundberg","year":"2005","unstructured":"Lundberg JO, Weitzberg E (2005) NO generation from nitrite and its role in vascular control. Arterioscler Thromb Vasc Biol 25:915\u2013922","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2045_CR14","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/sj.bjp.0701815","volume":"124","author":"DD Rees","year":"1998","unstructured":"Rees DD, Monkhouse JE, Cambridge D, Moncada S (1998) Nitric oxide and the haemodynamic profile of endotoxin shock in the conscious mouse. Br J Pharmacol 124:540\u2013546","journal-title":"Br J Pharmacol"},{"key":"2045_CR15","first-page":"H1038","volume":"259","author":"G Julou-Schaeffer","year":"1990","unstructured":"Julou-Schaeffer G, Gray GA, Fleming I, Schott C, Parratt JR, Stoclet JC (1990) Loss of vascular responsiveness induced by endotoxin involves l-arginine pathway. Am J Physiol 259:H1038\u2013H1043","journal-title":"Am J Physiol"},{"key":"2045_CR16","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.1161\/01.RES.87.7.e18","volume":"87","author":"WA Boyle 3rd","year":"2000","unstructured":"Boyle WA 3rd, Parvathaneni LS, Bourlier V, Sauter C, Laubach VE, Cobb JP (2000) iNOS gene expression modulates microvascular responsiveness in endotoxin-challenged mice. Circ Res 87:E18\u2013E24","journal-title":"Circ Res"},{"key":"2045_CR17","first-page":"415","volume":"4","author":"TA Walker","year":"1995","unstructured":"Walker TA, Curtis SE, King-VanVlack CE, Chapler CK, Vallet B, Cain SM (1995) Effects of nitric oxide synthase inhibition on regional hemodynamics and oxygen transport in endotoxic dogs. Shock 4:415\u2013420","journal-title":"Shock"},{"key":"2045_CR18","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1164\/ajrccm.161.6.9812004","volume":"161","author":"JL Vincent","year":"2000","unstructured":"Vincent JL, Zhang H, Szabo C, Preiser JC (2000) Effects of nitric oxide in septic shock. Am J Respir Crit Care Med 161:1781\u20131785","journal-title":"Am J Respir Crit Care Med"},{"key":"2045_CR19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.CCM.0000105581.01815.C6","volume":"32","author":"A Lopez","year":"2004","unstructured":"Lopez A, Lorente JA, Steingrub J, Bakker J, McLuckie A, Willatts S, Brockway M, Anzueto A, Holzapfel L, Breen D, Silverman MS, Takala J, Donaldson J, Arneson C, Grove G, Grossman S, Grover R (2004) Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 32:21\u201330","journal-title":"Crit Care Med"},{"key":"2045_CR20","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00024382-199902000-00005","volume":"11","author":"B Levy","year":"1999","unstructured":"Levy B, Valtier M, de Chillou C, Bollaert PE, Cane D, Mallie JP (1999) Beneficial effects of l-canavanine, a selective inhibitor of inducible nitric oxide synthase, on lactate metabolism and muscle high energy phosphates during endotoxic shock in rats. Shock 11:98\u2013103","journal-title":"Shock"},{"key":"2045_CR21","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/sj.ki.5002340","volume":"72","author":"A Cauwels","year":"2007","unstructured":"Cauwels A (2007) Nitric oxide in shock. Kidney Int 72:557\u2013565","journal-title":"Kidney Int"},{"key":"2045_CR22","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1084\/jem.20091236","volume":"206","author":"A Cauwels","year":"2009","unstructured":"Cauwels A, Buys ES, Thoonen R, Geary L, Delanghe J, Shiva S, Brouckaert P (2009) Nitrite protects against morbidity and mortality associated with TNF- or LPS-induced shock in a soluble guanylate cyclase-dependent manner. J Exp Med 206:2915\u20132924","journal-title":"J Exp Med"},{"key":"2045_CR23","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1097\/00003246-200005000-00046","volume":"28","author":"P Wang","year":"2000","unstructured":"Wang P, Zhou M, Cioffi WG, Bland KI, Ba ZF, Chaudry IH (2000) Is prostacyclin responsible for producing the hyperdynamic response during early sepsis? Crit Care Med 28:1534\u20131539","journal-title":"Crit Care Med"},{"key":"2045_CR24","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1096\/fj.03-0609fje","volume":"18","author":"S Schildknecht","year":"2004","unstructured":"Schildknecht S, Bachschmid M, Baumann A, Ullrich V (2004) COX-2 inhibitors selectively block prostacyclin synthesis in endotoxin-exposed vascular smooth muscle cells. FASEB J 18:757\u2013759","journal-title":"FASEB J"},{"key":"2045_CR25","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1161\/HYPERTENSIONAHA.108.112029","volume":"52","author":"K H\u00f6cherl","year":"2008","unstructured":"H\u00f6cherl K, Schmidt C, Kurt B, Bucher M (2008) Activation of the PGI(2)\/IP system contributes to the development of circulatory failure in a rat model of endotoxic shock. Hypertension 52:330\u2013335","journal-title":"Hypertension"},{"key":"2045_CR26","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1056\/NEJM199703273361303","volume":"336","author":"GR Bernard","year":"1997","unstructured":"Bernard GR, Wheeler AP, Russell JA, Schein R, Summer WR, Steinberg KP, Fulkerson WJ, Wright PE, Christman BW, Dupont WD, Higgins SB, Swindell BB (1997) The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. N Engl J Med 336:912\u2013918","journal-title":"N Engl J Med"},{"key":"2045_CR27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1152\/physrev.00029.2006","volume":"87","author":"P Pacher","year":"2007","unstructured":"Pacher P, Beckman JS, Liaudet L (2007) Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87:315\u2013424","journal-title":"Physiol Rev"},{"key":"2045_CR28","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0014-5793(95)00322-Z","volume":"363","author":"C Szabo","year":"1995","unstructured":"Szabo C, Salzman AL, Ischiropoulos H (1995) Endotoxin triggers the expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in the rat aorta in vivo. FEBS Lett 363:235\u2013238","journal-title":"FEBS Lett"},{"key":"2045_CR29","doi-asserted-by":"crossref","first-page":"9753","DOI":"10.1073\/pnas.97.17.9753","volume":"97","author":"H Macarthur","year":"2000","unstructured":"Macarthur H, Westfall TC, Riley DP, Misko TP, Salvemini D (2000) Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock. Proc Natl Acad Sci U S A 97:9753\u20139758","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2045_CR30","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1126\/science.286.5438.304","volume":"286","author":"D Salvemini","year":"1999","unstructured":"Salvemini D, Wang ZQ, Zweier JL, Samouilov A, Macarthur H, Misko TP, Currie MG, Cuzzocrea S, Sikorski JA, Riley DP (1999) A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats. Science 286:304\u2013306","journal-title":"Science"},{"key":"2045_CR31","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1172\/JCI115820","volume":"89","author":"DW Landry","year":"1992","unstructured":"Landry DW, Oliver JA (1992) The ATP-sensitive K+ channel mediates hypotension in endotoxemia and hypoxic lactic acidosis in dog. J Clin Invest 89:2071\u20132074","journal-title":"J Clin Invest"},{"key":"2045_CR32","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.cardiores.2006.07.011","volume":"72","author":"JF Buckley","year":"2006","unstructured":"Buckley JF, Singer M, Clapp LH (2006) Role of KATP channels in sepsis. Cardiovasc Res 72:220\u2013230","journal-title":"Cardiovasc Res"},{"key":"2045_CR33","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/01.CCM.0000206114.19707.7C","volume":"34","author":"S Warrillow","year":"2006","unstructured":"Warrillow S, Egi M, Bellomo R (2006) Randomized, double-blind, placebo-controlled crossover pilot study of a potassium channel blocker in patients with septic shock. Crit Care Med 34:980\u2013985","journal-title":"Crit Care Med"},{"key":"2045_CR34","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/shk.0b013e3180556a3c","volume":"28","author":"A Morelli","year":"2007","unstructured":"Morelli A, Lange M, Ertmer C, Broeking K, Van Aken H, Orecchioni A, Rocco M, Bachetoni A, Traber DL, Landoni G, Pietropaoli P, Westphal M (2007) Glibenclamide dose response in patients with septic shock: effects on norepinephrine requirements, cardiopulmonary performance, and global oxygen transport. Shock 28:530\u2013535","journal-title":"Shock"},{"key":"2045_CR35","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/SHK.0b013e31815071e9","volume":"29","author":"A Cauwels","year":"2008","unstructured":"Cauwels A, Brouckaert P (2008) Critical role for small and large conductance calcium-dependent potassium channels in endotoxemia and TNF toxicity. Shock 29:577\u2013582","journal-title":"Shock"},{"key":"2045_CR36","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1161\/CIRCULATIONAHA.105.590232","volume":"114","author":"P Pickkers","year":"2006","unstructured":"Pickkers P, Dorresteijn MJ, Bouw MP, van der Hoeven JG, Smits P (2006) In vivo evidence for nitric oxide-mediated calcium-activated potassium-channel activation during human endotoxemia. Circulation 114:414\u2013421","journal-title":"Circulation"},{"key":"2045_CR37","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1097\/CCM.0b013e31817603ba","volume":"36","author":"PE Marik","year":"2008","unstructured":"Marik PE, Pastores SM, Annane D, Meduri GU, Sprung CL, Arlt W, Keh D, Briegel J, Beishuizen A, Dimopoulou I, Tsagarakis S, Singer M, Chrousos GP, Zaloga G, Bokhari F, Vogeser M (2008) Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 36:1937\u20131949","journal-title":"Crit Care Med"},{"key":"2045_CR38","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1164\/rccm.200509-1369OC","volume":"174","author":"D Annane","year":"2006","unstructured":"Annane D, Maxime V, Ibrahim F, Alvarez JC, Abe E, Boudou P (2006) Diagnosis of adrenal insufficiency in severe sepsis and septic shock. Am J Respir Crit Care Med 174:1319\u20131326","journal-title":"Am J Respir Crit Care Med"},{"key":"2045_CR39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa071366","volume":"358","author":"CL Sprung","year":"2008","unstructured":"Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, Laterre PF, Reinhart K, Cuthbertson BH, Payen D, Briegel J (2008) Hydrocortisone therapy for patients with septic shock. N Engl J Med 358:111\u2013124","journal-title":"N Engl J Med"},{"key":"2045_CR40","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1007\/s00134-009-1627-9","volume":"35","author":"J Briegel","year":"2009","unstructured":"Briegel J, Sprung CL, Annane D, Singer M, Keh D, Moreno R, Mohnle P, Weiss Y, Avidan A, Brunkhorst FM, Fiedler F, Vogeser M (2009) Multicenter comparison of cortisol as measured by different methods in samples of patients with septic shock. Intensive Care Med 35:2151\u20132156","journal-title":"Intensive Care Med"},{"key":"2045_CR41","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/00024382-199705000-00002","volume":"7","author":"LL Wu","year":"1997","unstructured":"Wu LL, Tang C, Liu MS (1997) Hyper- and hypocardiodynamic states are associated with externalization and internalization, respectively, of alpha-adrenergic receptors in rat heart during sepsis. Shock 7:318\u2013323","journal-title":"Shock"},{"key":"2045_CR42","first-page":"185","volume":"19","author":"M McMillan","year":"1986","unstructured":"McMillan M, Chernow B, Roth BL (1986) Hepatic alpha 1-adrenergic receptor alteration in a rat model of chronic sepsis. Circ Shock 19:185\u2013193","journal-title":"Circ Shock"},{"key":"2045_CR43","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/hep.1840200314","volume":"20","author":"TL Hwang","year":"1994","unstructured":"Hwang TL, Lau YT, Huang SF, Chen MF, Liu MS (1994) Changes of alpha 1-adrenergic receptors in human liver during intraabdominal sepsis. Hepatology 20:638\u2013642","journal-title":"Hepatology"},{"key":"2045_CR44","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/cc8026","volume":"13","author":"E Montmollin de","year":"2009","unstructured":"de Montmollin E, Aboab J, Mansart A, Annane D (2009) Bench-to-bedside review: \u03b2-adrenergic modulation in sepsis. Crit Care 13:230","journal-title":"Crit Care"},{"key":"2045_CR45","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2006.03.052","volume":"538","author":"ME Pacheco","year":"2006","unstructured":"Pacheco ME, Beltran A, Redondo J, Manso AM, Alonso MJ, Salaices M (2006) High glucose enhances inducible nitric oxide synthase expression. Role of protein kinase C-betaII. Eur J Pharmacol 538:115\u2013123","journal-title":"Eur J Pharmacol"},{"key":"2045_CR46","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1210\/en.2007-1558","volume":"149","author":"B Ellger","year":"2008","unstructured":"Ellger B, Richir MC, van Leeuwen PA, Debaveye Y, Langouche L, Vanhorebeek I, Teerlink T, Van den Berghe G (2008) Glycemic control modulates arginine and asymmetrical-dimethylarginine levels during critical illness by preserving dimethylarginine-dimethylaminohydrolase activity. Endocrinology 149:3148\u20133157","journal-title":"Endocrinology"},{"key":"2045_CR47","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1553-2712.2010.00695.x","volume":"17","author":"JS Holger","year":"2010","unstructured":"Holger JS, Dries DJ, Barringer KW, Peake BJ, Flottemesch TJ, Marini JJ (2010) Cardiovascular and metabolic effects of high-dose insulin in a porcine septic shock model. Acad Emerg Med 17:429\u2013435","journal-title":"Acad Emerg Med"},{"key":"2045_CR48","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/jama.2010.516","volume":"303","author":"D Annane","year":"2010","unstructured":"Annane D, Cariou A, Maxime V, Azoulay E, D\u2019Honneur G, Timsit JF, Cohen Y, Wolf M, Fartoukh M, Adrie C, Santre C, Bollaert PE, Mathonet A, Amathieu R, Tabah A, Clec\u2019h C, Mayaux J, Lejeune J, Chevret S (2010) Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA 303:341\u2013348","journal-title":"JAMA"},{"key":"2045_CR49","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1476-5381.1993.tb13563.x","volume":"109","author":"JA Mitchell","year":"1993","unstructured":"Mitchell JA, Kohlhaas KL, Sorrentino R, Warner TD, Murad F, Vane JR (1993) Induction by endotoxin of nitric oxide synthase in the rat mesentery: lack of effect on action of vasoconstrictors. Br J Pharmacol 109:265\u2013270","journal-title":"Br J Pharmacol"},{"key":"2045_CR50","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/01.CIR.100.2.107","volume":"100","author":"JC Stoclet","year":"1999","unstructured":"Stoclet JC, Martinez MC, Ohlmann P, Chasserot S, Schott C, Kleschyov AL, Schneider F, Andriantsitohaina R (1999) Induction of nitric oxide synthase and dual effects of nitric oxide and cyclooxygenase products in regulation of arterial contraction in human septic shock. Circulation 100:107\u2013112","journal-title":"Circulation"},{"key":"2045_CR51","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/S0140-6736(02)11393-6","volume":"360","author":"PE Spronk","year":"2002","unstructured":"Spronk PE, Ince C, Gardien MJ, Mathura KR, Oudemans-van Straaten HM, Zandstra DF (2002) Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet 360:1395\u20131396","journal-title":"Lancet"},{"key":"2045_CR52","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00134-007-0934-2","volume":"34","author":"RP Dellinger","year":"2008","unstructured":"Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL (2008) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 34:17\u201360","journal-title":"Intensive Care Med"},{"key":"2045_CR53","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","volume":"362","author":"D Backer De","year":"2010","unstructured":"De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, Brasseur A, Defrance P, Gottignies P, Vincent JL (2010) Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 362:779\u2013789","journal-title":"N Engl J Med"},{"key":"2045_CR54","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1097\/00003246-200008000-00007","volume":"28","author":"D LeDoux","year":"2000","unstructured":"LeDoux D, Astiz ME, Carpati CM, Rackow EC (2000) Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 28:2729\u20132732","journal-title":"Crit Care Med"},{"key":"2045_CR55","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1097\/00003246-199112000-00021","volume":"19","author":"MJ Breslow","year":"1991","unstructured":"Breslow MJ, Ligier B (1991) Hyperadrenergic states. Crit Care Med 19:1566\u20131579","journal-title":"Crit Care Med"},{"key":"2045_CR56","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJM199602293340907","volume":"334","author":"PA Insel","year":"1996","unstructured":"Insel PA (1996) Seminars in medicine of the Beth Israel Hospital, Boston. Adrenergic receptors\u2014evolving concepts and clinical implications. N Engl J Med 334:580\u2013585","journal-title":"N Engl J Med"},{"key":"2045_CR57","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1358\/mf.2006.28.5.990203","volume":"28","author":"S Katsaragakis","year":"2006","unstructured":"Katsaragakis S, Kapralou A, Theodorou D, Markogiannakis H, Larentzakis A, Stamou KM, Drimousis P, Bramis I (2006) Refractory septic shock: efficacy and safety of very high doses of norepinephrine. Methods Find Exp Clin Pharmacol 28:307\u2013313","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"2045_CR58","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00134-007-0946-y","volume":"34","author":"M Lange","year":"2008","unstructured":"Lange M, Ertmer C, Westphal M (2008) Vasopressin vs. terlipressin in the treatment of cardiovascular failure in sepsis. Intensive Care Med 34:821\u2013832","journal-title":"Intensive Care Med"},{"key":"2045_CR59","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1097\/00003246-200110000-00002","volume":"29","author":"MY Kirov","year":"2001","unstructured":"Kirov MY, Evgenov OV, Evgenov NV, Egorina EM, Sovershaev MA, Sveinbjornsson B, Nedashkovsky EV, Bjertnaes LJ (2001) Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study. Crit Care Med 29:1860\u20131867","journal-title":"Crit Care Med"},{"key":"2045_CR60","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1097\/00003246-200207000-00057","volume":"30","author":"PM Honore","year":"2002","unstructured":"Honore PM, Matson JR (2002) Short-term high-volume hemofiltration in sepsis: perhaps the right way is to start with. Crit Care Med 30:1673\u20131674","journal-title":"Crit Care Med"},{"key":"2045_CR61","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1007\/s00134-002-1375-6","volume":"28","author":"K Ataman","year":"2002","unstructured":"Ataman K, Jehmlich M, Kock S, Neumann S, Leischik M, Filipovic Z, Hopf HB (2002) Short-term cardiovascular effects of plasmapheresis in norepinephrine-refractory septic shock. Intensive Care Med 28:1164\u20131167","journal-title":"Intensive Care Med"},{"key":"2045_CR62","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/01.CIR.95.5.1122","volume":"95","author":"DW Landry","year":"1997","unstructured":"Landry DW, Levin HR, Gallant EM, Ashton RC Jr, Seo S, D\u2019Alessandro D, Oz MC, Oliver JA (1997) Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 95:1122\u20131125","journal-title":"Circulation"},{"key":"2045_CR63","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00003246-200203000-00001","volume":"30","author":"T Sharshar","year":"2002","unstructured":"Sharshar T, Carlier R, Blanchard A, Feydy A, Gray F, Paillard M, Raphael JC, Gajdos P, Annane D (2002) Depletion of neurohypophyseal content of vasopressin in septic shock. Crit Care Med 30:497\u2013500","journal-title":"Crit Care Med"},{"key":"2045_CR64","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1097\/01.CCM.0000206466.56669.BE","volume":"34","author":"M Leone","year":"2006","unstructured":"Leone M, Boyle WA (2006) Decreased vasopressin responsiveness in vasodilatory septic shock-like conditions. Crit Care Med 34:1126\u20131130","journal-title":"Crit Care Med"},{"key":"2045_CR65","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","volume":"358","author":"JA Russell","year":"2008","unstructured":"Russell JA, Walley KR, Singer J, Gordon AC, Hebert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D (2008) Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 358:877\u2013887","journal-title":"N Engl J Med"},{"key":"2045_CR66","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/01.CCM.0000153526.24976.83","volume":"33","author":"M Westphal","year":"2005","unstructured":"Westphal M, Traber DL (2005) Low-dose terlipressin for hemodynamic support in sepsis and systemic inflammatory response syndrome: art for (he)art\u2019s sake or state of the art? Crit Care Med 33:455\u2013457","journal-title":"Crit Care Med"},{"key":"2045_CR67","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/shk.0b013e318063e63b","volume":"29","author":"K Broking","year":"2008","unstructured":"Broking K, Lange M, Morelli A, Ertmer C, Aken HV, Luecke M, Rehberg S, Bowering N, Bone HG, Traber DL, Westphal M (2008) Employing dobutamine as a useful agent to reverse the terlipressin-linked impairments in cardiopulmonary hemodynamics and global oxygen transport in healthy and endotoxemic sheep. Shock 29:71\u201377","journal-title":"Shock"},{"key":"2045_CR68","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/shk.0b013e318050c836","volume":"28","author":"M Lange","year":"2007","unstructured":"Lange M, Morelli A, Ertmer C, Broking K, Rehberg S, Van Aken H, Traber DL, Westphal M (2007) Role of adenosine triphosphate-sensitive potassium channel inhibition in shock states: physiology and clinical implications. Shock 28:394\u2013400","journal-title":"Shock"},{"key":"2045_CR69","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","volume":"344","author":"GR Bernard","year":"2001","unstructured":"Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699\u2013709","journal-title":"N Engl J Med"},{"key":"2045_CR70","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1182\/blood-2006-09-003004","volume":"109","author":"LO Mosnier","year":"2007","unstructured":"Mosnier LO, Zlokovic BV, Griffin JH (2007) The cytoprotective protein C pathway. Blood 109:3161\u20133172","journal-title":"Blood"},{"key":"2045_CR71","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/01.moh.0000239712.93662.35","volume":"13","author":"CT Esmon","year":"2006","unstructured":"Esmon CT (2006) The endothelial protein C receptor. Curr Opin Hematol 13:382\u2013385","journal-title":"Curr Opin Hematol"},{"key":"2045_CR72","doi-asserted-by":"crossref","first-page":"11199","DOI":"10.1074\/jbc.C100017200","volume":"276","author":"DE Joyce","year":"2001","unstructured":"Joyce DE, Gelbert L, Ciaccia A, DeHoff B, Grinnell BW (2001) Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis. J Biol Chem 276:11199\u201311203","journal-title":"J Biol Chem"},{"key":"2045_CR73","doi-asserted-by":"crossref","unstructured":"Bilbault P, Lavaux T, Launoy A, Gaub MP, Meyer N, Oudet P, Pottecher T, Jaeger A, Schneider F (2007) Influence of drotrecogin alpha (activated) infusion on the variation of Bax\/Bcl-2 and Bax\/Bcl-xl ratios in circulating mononuclear cells: a cohort study in septic shock patients. Crit Care Med 35:69\u201375","DOI":"10.1097\/01.CCM.0000251133.26979.F4"},{"key":"2045_CR74","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/CCM.0b013e318192fe4f","volume":"37","author":"S Nacira","year":"2009","unstructured":"Nacira S, Meziani F, Dessebe O, Cattan V, Collin S, Montemont C, Gibot S, Asfar P, Ramaroson A, Regnault V, Slama M, Lecompte T, Lacolley P, Levy B (2009) Activated protein C improves lipopolysaccharide-induced cardiovascular dysfunction by decreasing tissular inflammation and oxidative stress. Crit Care Med 37:246\u2013255","journal-title":"Crit Care Med"},{"key":"2045_CR75","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00134-006-0166-x","volume":"32","author":"R Favory","year":"2006","unstructured":"Favory R, Lancel S, Marechal X, Tissier S, Neviere R (2006) Cardiovascular protective role for activated protein C during endotoxemia in rats. Intensive Care Med 32:899\u2013905","journal-title":"Intensive Care Med"},{"key":"2045_CR76","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s00134-005-2792-0","volume":"31","author":"X Monnet","year":"2005","unstructured":"Monnet X, Lamia B, Anguel N, Richard C, Bonmarchand G, Teboul JL (2005) Rapid and beneficial hemodynamic effects of activated protein C in septic shock patients. Intensive Care Med 31:1573\u20131576","journal-title":"Intensive Care Med"},{"key":"2045_CR77","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/jama.288.7.862","volume":"288","author":"D Annane","year":"2002","unstructured":"Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troche G, Chaumet-Riffaut P, Bellissant E (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862\u2013871","journal-title":"JAMA"},{"key":"2045_CR78","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/cc2374","volume":"8","author":"H Prigent","year":"2004","unstructured":"Prigent H, Maxime V, Annane D (2004) Clinical review: corticotherapy in sepsis. Crit Care 8:122\u2013129","journal-title":"Crit Care"},{"key":"2045_CR79","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1097\/01.CCM.0000059646.89546.98","volume":"31","author":"E Kilger","year":"2003","unstructured":"Kilger E, Weis F, Briegel J, Frey L, Goetz AE, Reuter D, Nagy A, Schuetz A, Lamm P, Knoll A, Peter K (2003) Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery. Crit Care Med 31:1068\u20131074","journal-title":"Crit Care Med"},{"key":"2045_CR80","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/01.CCM.0B013E318161FAF3","volume":"36","author":"S Gibot","year":"2008","unstructured":"Gibot S, Massin F, Alauzet C, Montemont C, Lozniewski A, Bollaert PE, Levy B (2008) Effects of the TREM-1 pathway modulation during mesenteric ischemia-reperfusion in rats. Crit Care Med 36:504\u2013510","journal-title":"Crit Care Med"},{"key":"2045_CR81","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJMoa010307","volume":"345","author":"E Rivers","year":"2001","unstructured":"Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368\u20131377","journal-title":"N Engl J Med"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-010-2045-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00134-010-2045-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-010-2045-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T07:03:38Z","timestamp":1636527818000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00134-010-2045-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,23]]},"references-count":81,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["2045"],"URL":"https:\/\/doi.org\/10.1007\/s00134-010-2045-8","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,23]]}}}